GSK's Vaccine Protects Against Bird Flu
Posted on: Monday, 5 March 2007, 12:01 CST
Global drug giant GlaxoSmithKline said Monday new data indicate its bird-flu vaccine protects against different strains of the virus.
GSK said the data, which were presented at the International Symposium on Respiratory Viral Infections in Hong Kong, indicate its vaccine may help prevent a flu pandemic.
The data confirm that our pre-pandemic influenza vaccine has the ability to recognize and kill an H5N1 strain that is different to the one contained in the vaccine, said Jean Stephenne, president of GlaxoSmithKline Biologicals, the company's vaccine division.
This means that proactive administration of our pre-pandemic vaccine before or just after the start of the pandemic could help to substantially slow down the spread of disease.
In one study, GSK's vaccine, which contains an antigen from the Vietnam strain of H5N1, elicited a strong antibody response in humans against the Indonesian strain of the flu virus. The effect was 25 times greater when an adjuvant was used in conjunction with the vaccine.
Source: United Press International
Related Articles
- Scientist Warns Pandemic Flu Vaccine Could Take 6 Months
- MDRNA, Inc. Lead Candidate Demonstrates In Vivo Efficacy Against Seasonal and Pandemic Flu Strains
- VGX Pharmaceuticals' SynCon(TM) Pandemic Flu Vaccine Protects Against A Lethal Challenge of Live Virus in Pre-Clinical Animal Models
- Dynavax's Flu Vaccine Shows Immunity to Divergent and Potentially Pandemic Flu Strains in Preclinical Tests
- GSK Reports Significant Advance in H5N1 Pandemic Flu Vaccine Program
- GlaxoSmithKline Initiates Human Trial Program With Two H5N1 Pandemic Flu Vaccines
- New Vaccines Necessary for New Bird Flu Strain: U.S. Official
- Pandemic Flu-Vaccine Prototype Promising
- EU team develops vaccine for one bird-flu strain
- Labs Urged to Destroy Pandemic Flu Strain
 |
 |
User Comments (0)
RSS Feeds